ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,563Medicare Part D Prescriptions Filled, Including Refills

Rank: 92 out of 337

$533K Total Retail Price of All Prescriptions

Rank: 60 out of 337

363 Patients Receiving at Least One Drug in Part D
78%Patients 65 Years and Older
37% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Rhode Island
Lower avg

Schedule Two
Controlled Substances

9% of this provider’s 363 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

19% of this provider’s 363 patients filled at least one prescription for a schedule three drug, compared to an average of 7%.

Risky Drugs to Seniors

2% of this provider’s 6,253 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$62 was the average price of a prescription from this provider, compared to $51 among peers.

Prescriptions per Patient

24 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Rhode Island
SIMVASTATIN 542 439 1 1
LISINOPRIL 458 390 2 2
OMEPRAZOLE 353 235 3 4
HYDROCODONE-ACETAMINOPHEN 303 172 S3 4 13
METFORMIN HCL ER 297 212 5 52
ATORVASTATIN CALCIUM 285 219 6 7
LEVOTHYROXINE SODIUM 245 185 7 5
AMLODIPINE BESYLATE 213 194 8 3
OXYCONTIN 208 29 S2 9 87
HYDROCHLOROTHIAZIDE 202 180 10 9
METOPROLOL TARTRATE 185 161 11 6
MELOXICAM 138 117 12 54
METHYLPREDNISOLONE 133 83 13 175
QUINAPRIL HCL 119 115 14 50
GABAPENTIN 113 48 15 20
CITALOPRAM HBR 112 83 16 17
FUROSEMIDE 105 88 17 8
LOSARTAN POTASSIUM 105 103 17 15
ZOLPIDEM TARTRATE 105 62 17 23
FENTANYL 102 15 S2 20 138
SYNTHROID 99 75 21 41
METFORMIN HCL 98 87 22 12
LISINOPRIL-HYDROCHLOROTHIAZIDE 97 60 23 31
RAMIPRIL 90 90 24 80
LORAZEPAM 85 62 25 119
LIPITOR 83 70 26 33
CYCLOBENZAPRINE HCL 77 41 R 27 103
AMLODIPINE BESYLATE-BENAZEPRIL 75 58 28 97
PANTOPRAZOLE SODIUM 75 65 28 36
NAPROXEN 73 32 30 98
TAMSULOSIN HCL 73 72 30 25
AZITHROMYCIN 71 49 32 51
ATENOLOL 67 67 33 10
WARFARIN SODIUM 64 64 34 11
PROAIR HFA 64 28 34 38
VENLAFAXINE HCL ER 60 35 36 86
PRAVASTATIN SODIUM 59 59 37 14
METOPROLOL SUCCINATE 57 56 38 21
NEXIUM 56 21 39 56
AMOX TR-POTASSIUM CLAVULANATE 56 35 39 137
AMITRIPTYLINE HCL 53 20 R 41 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.